From the onset of the coronavirus outbreak, healthcare workers and scientists have been working tirelessly to study the virus, test drugs and vaccines, and control the disease’s spread. At QIAGEN, we will do everything we can to support every step of this effort – it is in times like these that our commitment to “making improvements in life possible” means more to us than ever.

Finding a rare allele or mutant sequence is a typical needle in a haystack problem. A novel fully integrated nanoplate-based digital PCR technology combines the power of partitioning with the ease of use of qPCR, making absolute quantification of the rare less challenging and more accessible. Discover top applications, rapid workflow, scalable products, and more.

Intense flu activity across the US means higher testing volume. QIAstat-Dx improves multiplex respiratory testing efficiency with a seamless bidirectional LIS interface, and provides deeper insights with Ct values and amplification curves.

If you’re setting up a new lab, you’ll probably want advice on how to make a successful start. Our New Lab Start-Up Program aims to kick-start your new project and make it a success from the outset. Read on to find out how we can get you up and running quickly, accelerate your research and help you stay within budget.

QIAGEN is celebrating the placement of its 2500th QIAsymphony SP with the Cenata GmbH in Tübingen, Germany. Cenata GmbH is a medically led genetic diagnostic laboratory offering prenatal testing, and repeat customer of the QIAsymphony.